Trial intelligence / Profile preview

Phase 3 trial of oral AND017 for anemia in non-dialysis chronic kidney disease

CTR20253576Phase 3Active

Sponsor
Ando Pharma
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of AND017 in anemia of chronic kidney disease, sponsored by Ando Pharma. Started Dec 2025; status: active.

02

Drugs

AND017
03

Conditions

anemia of chronic kidney disease

Beyond the preview

Go deeper on CTR20253576.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20253576.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call